Biostock interview with Chordate CEO: “Chordate Medical trains leading UK neurology hospital

Biostock interviews Chordate’s CEO Anders Weilandt regarding the company’s recent training day for neurologists and nurses at the neurological hospital The Walton Center in Liverpool.

“Right now, we are fully focused on supporting customers who want to get started with practical use in our chosen markets. This applies to all markets that we are present on. Of course, in the beginning, it is a matter of a few clinics in each market. But this is generally how it starts, first with one step and then one step at a time”, says Anders weilandt.

Read the full interview

More posts

For questions about Chordate’s share price or other investment-related topics, please see if the answer is here.

For questions about the medical effects of Ozilia® Migraine, please see if the answer is here.

To get in touch with Chordate regarding other questions, use the adjecent form. We do our best to respond as quickly as possible.

Please note that the MAR rules (Market Abuse Regulation) prohibits us from providing information to individual inquirers regarding matters of the company’s share, share price, economy and financials, commercial and scientific activities, and other information that potentially can alter the Market valuation of the traded share. We refer in general to the public information published by the company for such questions. Hence, emails with such questions will not be responded to individually.

Contact us

  • This field is for validation purposes and should be left unchanged.

The information is handled according to our privacy policy